Bone Biopsy Market Research Report Information by Type (Needle Biopsy, Open Biopsy), by Guided (MRI-Guided and CT-Guided), by End User (Hospitals & Clinics, Surgical Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and the Rest of the World)—Forecast till 2032

LIST OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF BONE CANCER

4.2.2 GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES

4.2.3 INCREASING ACCEPTANCE OF BONE MARROW BIOPSY FOR DIAGNOSIS AND TREATMENT OF LYMPHOMA AND LEUKEMIA DISEASE

4.3 RESTRAINTS

4.4 OPPORTUNITIES

4.4.1 IMPROVING HEALTHCARE INFRASTRUCTURE ACROSS EMERGING COUNTRIES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D AND DESIGNING

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES REVIEW

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF BUYERS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19

5.3.1 IMPACT ON DEMAND

5.3.2 IMPACT ON SUPPLY CHAIN

6 GLOBAL BONE BIOPSY MARKET, BY TYPE

6.1 OVERVIEW

6.2 NEEDLE BIOPSY

6.3 OPEN BIOPSY

7 GLOBAL BONE BIOPSY MARKET, BY GUIDED

7.1 OVERVIEW

7.2 MRI-GUIDED

7.3 CT-GUIDED

8 GLOBAL BONE BIOPSY MARKET, BY END USER

8.1 OVERVIEW

8.2 HOSPITALS AND CLINICS

8.3 SURGICAL CENTERS

8.4 OTHERS

9 GLOBAL BONE BIOPSY MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.3 EUROPE

9.3.1 GERMANY

9.3.2 UK

9.3.3 FRANCE

9.3.4 ITALY

9.3.5 SPAIN

9.3.6 REST OF EUROPE

9.4 ASIA-PACIFIC

9.4.1 JAPAN

9.4.2 CHINA

9.4.3 INDIA

9.4.4 AUSTRALIA

9.4.5 SOUTH KOREA

9.4.6 REST OF ASIA-PACIFIC

9.5 REST OF THE WORLD

9.5.1 MIDDLE EAST

9.5.2 AFRICA

9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW

10.2 COMPETITIVE BENCHMARKING

10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL BONE BIOPSY MARKET

10.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL BONE BIOPSY MARKET

10.5 KEY DEVELOPMENT ANALYSIS

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

10.6.2 PARTNERSHIP/COLLABORATION

10.7 MAJOR PLAYERS FINANCIAL MATRIX

10.7.1 SALES 2021

10.7.2 R&D EXPENDITURE (USD MILLION), 2021

11.1 ARGON MEDICAL

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 B. BRAUN MELSUNGEN AG

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 SWOT ANALYSIS

11.2.6 KEY STRATEGIES

11.3 BECTON, DICKINSON, AND COMPANY

11.3.1 COMPANY OVERVIEW

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 SWOT ANALYSIS

11.3.6 KEY STRATEGIES

11.4 CARDINAL HEALTH

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL OVERVIEW

11.4.3 PRODUCTS OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 SWOT ANALYSIS

11.4.6 KEY STRATEGIES

11.5 MERMAID MEDICAL GROUP

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL OVERVIEW

11.5.3 PRODUCTS OFFERED

11.5.4 KEY DEVELOPMENTS

11.5.5 KEY STRATEGIES

11.6 KIMAL PLC

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 PRODUCTS OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 KEY STRATEGIES

11.7 STRYKER

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 SWOT ANALYSIS

11.7.6 KEY STRATEGIES

11.8 COOK MEDICAL

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS/S OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 SWOT ANALYSIS

11.8.6 KEY STRATEGIES

11.9 REMINGTON MEDICAL

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS OFFERED

11.9.4 KEY DEVELOPMENTS

11.9.5 KEY STRATEGIES

11.10 MERIT MEDICAL SYSTEMS

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 SWOT ANALYSIS

11.10.6 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES

12.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 4 GLOBAL BONE BIOPSY MARKET, FOR NEEDLE BIOPSY, BY REGION, 2018–2030 (USD MILLION)

TABLE 5 GLOBAL BONE BIOPSY MARKET, FOR OPEN BIOPSY, BY REGION, 2018–2030 (USD MILLION)

TABLE 6 GLOBAL BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 7 GLOBAL BONE BIOPSY MARKET, FOR MRI-GUIDED, BY REGION, 2018–2030 (USD MILLION)

TABLE 8 GLOBAL BONE BIOPSY MARKET, FOR CT-GUIDED, BY REGION, 2018–2030 (USD MILLION)

TABLE 9 GLOBAL BONE BIOPSY MARKET, BY END USER 2018–2030 (USD MILLION)

TABLE 10 GLOBAL BONE BIOPSY MARKET, FOR HOSPITALS AND CLINICS, BY REGION, 2018–2030 (USD MILLION)

TABLE 11 GLOBAL BONE BIOPSY MARKET, FOR SURGICAL CENTERS, BY REGION, 2018–2030 (USD MILLION)

TABLE 12 GLOBAL BONE BIOPSY MARKET, FOR OTHERS, BY REGION, 2018–2030 (USD MILLION)

TABLE 13 GLOBAL: BONE BIOPSY MARKET, BY REGION, 2018-2030 (USD MILLION)

TABLE 14 NORTH AMERICA: BONE BIOPSY MARKET, BY COUNTRY, 2018-2030 (USD MILLION)

TABLE 15 NORTH AMERICA: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 16 NORTH AMERICA: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 17 NORTH AMERICA: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 18 US: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 19 US: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 20 US : BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 21 CANADA: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 22 CANADA: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 23 CANADA: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 24 EUROPE: BONE BIOPSY MARKET, BY COUNTRY, 2018-2030 (USD MILLION)

TABLE 25 EUROPE: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 26 EUROPE: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 27 EUROPE: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 28 GERMANY: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 29 GERMANY: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 30 GERMANY: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 31 UK: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 32 UK: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 33 UK: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 34 FRANCE: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 35 FRANCE: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 36 FRANCE: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 37 ITALY: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 38 ITALY: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 39 ITALY: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 40 SPAIN: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 41 SPAIN: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 42 SPAIN: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 43 REST OF EUROPE: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 44 REST OF EUROPE: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 45 REST OF EUROPE: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 46 ASIA-PACIFIC: BONE BIOPSY MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 47 ASIA-PACIFIC: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 48 ASIA-PACIFIC: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 49 ASIA-PACIFIC: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 50 JAPAN: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 51 JAPAN: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 52 JAPAN: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 53 CHINA: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 54 CHINA: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 55 CHINA: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 56 INDIA: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 57 INDIA: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 58 INDIA: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 59 AUSTRALIA: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 60 AUSTRALIA: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 61 AUSTRALIA: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 62 SOUTH KOREA: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 63 SOUTH KOREA: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 64 SOUTH KOREA: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 65 REST OF ASIA-PACIFIC: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 66 REST OF ASIA-PACIFIC: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 67 REST OF ASIA-PACIFIC: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 68 REST OF THE WORLD: BONE BIOPSY MARKET, BY REGION, 2018-2030 (USD MILLION)

TABLE 69 REST OF THE WORLD: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 70 REST OF THE WORLD: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 71 REST OF THE WORLD: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 72 MIDDLE EAST: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 73 MIDDLE EAST: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 74 MIDDLE EAST: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 75 AFRICA: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 76 AFRICA: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 77 AFRICA: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 78 LATIN AMERICA: BONE BIOPSY MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 79 LATIN AMERICA: BONE BIOPSY MARKET, BY GUIDED, 2018–2030 (USD MILLION)

TABLE 80 LATIN AMERICA: BONE BIOPSY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 81 MAJOR PLAYERS IN THE GLOBAL BONE BIOPSY MARKET

TABLE 82 MOST ACTIVE PLAYERS IN THE GLOBAL BONE BIOPSY MARKET

TABLE 83 PRODUCT LAUNCH/PRODUCT APPROVAL

TABLE 84 PARTNERSHIP/COLLABORATION

TABLE 85 ARGON MEDICAL: PRODUCTS OFFERED

TABLE 86 ARGON MEDICAL: KEY DEVELOPMENTS

TABLE 87 B. BRAUN MELSUNGEN AG: PRODUCTS OFFERED

TABLE 88 BECTON, DICKINSON, AND COMPANY: PRODUCTS OFFERED

TABLE 89 CARDINAL HEALTH: PRODUCTS OFFERED

TABLE 90 MERMAID MEDICAL GROUP: PRODUCTS OFFERED

TABLE 91 KIMAL PLC: PRODUCTS OFFERED

TABLE 92 STRYKER: PRODUCTS OFFERED

TABLE 93 COOK: PRODUCTS/ OFFERED

TABLE 94 REMINGTON MEDICAL: PRODUCTSOFFERED

TABLE 95 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED

TABLE 96 MERIT MEDICAL SYSTEMS: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL BONE BIOPSY MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: GLOBAL BONE BIOPSY MARKET

FIGURE 5 DRIVERS: IMPACT ANALYSIS

FIGURE 6 RESTRAINT: IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN: GLOBAL BONE BIOPSY MARKET

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL BONE BIOPSY MARKET

FIGURE 9 GLOBAL BONE BIOPSY MARKET, BY TYPE, 2021 & 2030 (USD MILLION)

FIGURE 10 GLOBAL BONE BIOPSY MARKET SHARE, BY TYPE, 2021 (%)

FIGURE 11 GLOBAL BONE BIOPSY MARKET, BY GUIDED, 2021 & 2030 (USD MILLION)

FIGURE 12 GLOBAL BONE BIOPSY MARKET SHARE, BY GUIDED, 2021 (%)

FIGURE 13 GLOBAL BONE BIOPSY MARKET, BY END USER, 2021 & 2030 (USD MILLION)

FIGURE 14 GLOBAL BONE BIOPSY MARKET SHARE, BY END USER, 2021 (%)

FIGURE 15 GLOBAL: BONE BIOPSY MARKET, BY REGION 2021 & 2030 (USD MILLION)

FIGURE 16 GLOBAL: BONE BIOPSY MARKET SHARE (%), BY REGION, 2021

FIGURE 17 NORTH AMERICA: BONE BIOPSY MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 18 EUROPE: BONE BIOPSY MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 19 ASIA-PACIFIC: BONE BIOPSY MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 20 REST OF THE WORLD: BONE BIOPSY MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 21 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 22 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL BONE BIOPSY MARKET

FIGURE 23 GLOBAL BONE BIOPSY MARKET: COMPETITIVE LANDSCAPE

FIGURE 24 SALES 2021

FIGURE 25 R&D EXPENDITURE (USD MILLION), 2021

FIGURE 26 ARGON MEDICAL: SWOT ANALYSIS

FIGURE 27 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS

FIGURE 29 BECTON, DICKINSON, AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 BECTON, DICKINSON, AND COMPANY: SWOT ANALYSIS

FIGURE 31 CARDINAL HEALTH: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 CARDINAL HEALTH, INC.: SWOT ANALYSIS

FIGURE 33 STRYKER: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 STRYKER: SWOT ANALYSIS

FIGURE 35 COOK: SWOT ANALYSIS

FIGURE 36 MERIT MEDICAL SYSTEMS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 37 MERIT MEDICAL SYSTEMS: SWOT ANALYSIS